CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,000 | -9.3% | 9,756 | +8.5% | 0.00% | – |
| Q2 2023 | $97,000 | +546.7% | 8,991 | +499.8% | 0.00% | – |
| Q1 2023 | $15,000 | -68.1% | 1,499 | -66.8% | 0.00% | – |
| Q4 2022 | $47,000 | +840.0% | 4,513 | +1097.1% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 377 | -34.4% | 0.00% | – |
| Q2 2022 | $7,000 | -75.9% | 575 | -79.1% | 0.00% | – |
| Q1 2022 | $29,000 | -71.3% | 2,747 | -57.9% | 0.00% | – |
| Q4 2021 | $101,000 | +57.8% | 6,528 | +132.3% | 0.00% | – |
| Q3 2021 | $64,000 | +178.3% | 2,810 | +209.8% | 0.00% | – |
| Q2 2021 | $23,000 | -55.8% | 907 | -27.9% | 0.00% | – |
| Q1 2021 | $52,000 | – | 1,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |